HK1048071A1 - 预防运动障碍的方法 - Google Patents

预防运动障碍的方法 Download PDF

Info

Publication number
HK1048071A1
HK1048071A1 HK03100309.3A HK03100309A HK1048071A1 HK 1048071 A1 HK1048071 A1 HK 1048071A1 HK 03100309 A HK03100309 A HK 03100309A HK 1048071 A1 HK1048071 A1 HK 1048071A1
Authority
HK
Hong Kong
Prior art keywords
ethanesulfinyl
piperidin
benzooxazol
hydroxy
compound
Prior art date
Application number
HK03100309.3A
Other languages
English (en)
Chinese (zh)
Inventor
伦纳德‧T‧梅尔策
倫納德‧T‧梅爾策
保尔‧J‧贝达德
保爾‧J‧貝達德
Original Assignee
沃纳-兰伯特公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 沃纳-兰伯特公司 filed Critical 沃纳-兰伯特公司
Publication of HK1048071A1 publication Critical patent/HK1048071A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
HK03100309.3A 2001-04-23 2003-01-14 预防运动障碍的方法 HK1048071A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28587001P 2001-04-23 2001-04-23
US60/285,870 2001-04-23

Publications (1)

Publication Number Publication Date
HK1048071A1 true HK1048071A1 (zh) 2003-03-21

Family

ID=23096048

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100309.3A HK1048071A1 (zh) 2001-04-23 2003-01-14 预防运动障碍的方法

Country Status (12)

Country Link
US (1) US20030004187A1 (cg-RX-API-DMAC7.html)
EP (1) EP1254661A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002332246A (cg-RX-API-DMAC7.html)
KR (1) KR20020082151A (cg-RX-API-DMAC7.html)
CN (1) CN1382442A (cg-RX-API-DMAC7.html)
AU (1) AU3439602A (cg-RX-API-DMAC7.html)
CA (1) CA2381630A1 (cg-RX-API-DMAC7.html)
HK (1) HK1048071A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0201336A3 (cg-RX-API-DMAC7.html)
IL (1) IL149148A0 (cg-RX-API-DMAC7.html)
PL (1) PL353582A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200203180B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005432B2 (en) 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
CA2684550A1 (en) * 2007-04-24 2008-10-30 Boehringer Ingelheim International Gmbh Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
DE102007047737A1 (de) * 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
EP3233077A4 (en) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
KR101657420B1 (ko) * 2015-08-31 2016-10-14 고려공업검사 주식회사 열교환기 튜브 검사용 홀더
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1024799A1 (en) * 1997-10-24 2000-08-09 Warner-Lambert Company Method for treating disease-related or drug-induced dyskinesias
PE20000728A1 (es) * 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda

Also Published As

Publication number Publication date
HU0201336D0 (cg-RX-API-DMAC7.html) 2002-06-29
IL149148A0 (en) 2002-11-10
EP1254661A1 (en) 2002-11-06
AU3439602A (en) 2002-10-24
CA2381630A1 (en) 2002-10-23
KR20020082151A (ko) 2002-10-30
PL353582A1 (en) 2002-11-04
US20030004187A1 (en) 2003-01-02
HUP0201336A3 (en) 2004-07-28
ZA200203180B (en) 2003-10-22
JP2002332246A (ja) 2002-11-22
HUP0201336A2 (hu) 2004-04-28
CN1382442A (zh) 2002-12-04

Similar Documents

Publication Publication Date Title
HK1048071A1 (zh) 预防运动障碍的方法
Löschmann et al. Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease
CN1310644C (zh) 药物组合产品及其在治疗胃肠疾病中的应用
JP2005523898A5 (ja) 運動障害治療剤
CN104411301B (zh) 适于改善运动障碍治疗的口服药物配方
JPH062672B2 (ja) パーキンソン疾患治療用薬剤
EP3897641B1 (en) Treatment of movement disorders
EP1154795B1 (en) Means for treating and diagnosing restless legs syndrome
AU760800B2 (en) Method for treating disease-related or drug-induced dyskinesias
US20110008431A1 (en) Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia
CN1243540C (zh) 用于治疗阿尔茨海默氏型老年性痴呆的活性组分的组合
CN101076328A (zh) 用于睡眠障碍的预防或治疗剂
CN1348372A (zh) 药物用途
CN1681491A (zh) 运动障碍的治疗
CN1527712A (zh) 用于药物治疗尼古丁依赖的活性成分组合物
MXPA00001570A (en) Method for treating disease-related or drug-induced dyskinesias
JP3381198B2 (ja) １，４−ジヒドロピリジンの糖尿病における使用
JP6134703B2 (ja) ジスキネジーの治療方法
CN1761467A (zh) 2－取代－吡啶－甲胺衍生物在制备用于治疗神经性和心理性慢性疼痛症状的药物的用途
JP2002255820A (ja) モノアミン作動性神経の活性化剤
HK1092058A (en) Treatment of depression and other affective disorders
HK1072893A (en) New treatments for restless legs syndrome
HK1053266A1 (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
HK1082681A (en) Combination therapy wherein a serotonin reuptake inhibitor is used
HK1096860A (en) Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action